Daesang Holdings Co., Ltd. (KRX:084690)
South Korea
· Delayed Price · Currency is KRW 9,630.00
+120.00 (1.26%)
Last updated: Apr 29, 2026, 2:43 PM KST
Daesang Holdings Revenue
In the year 2025, Daesang Holdings had annual revenue of 5.63T KRW with 5.06% growth. Daesang Holdings had revenue of 1.35T in the quarter ending December 31, 2025, with 0.43% growth.
Revenue
5,628.80B
Revenue Growth
+5.06%
P/S Ratio
0.06
Revenue / Employee
112.58B
Employees
50
Market Cap
357.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5,628.80B | 270.91B | 5.06% |
| Dec 31, 2024 | 5,357.89B | 98.49B | 1.87% |
| Dec 31, 2023 | 5,259.40B | 32.74B | 0.63% |
| Dec 31, 2022 | 5,226.66B | 1,020.69B | 24.27% |
| Dec 31, 2021 | 4,205.97B | 451.67B | 12.03% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Namyang Dairy Products | 914.15B |
| EASY HOLDINGS | 3,388.90B |
| Samlip | 3,370.48B |
| Kwang Dong Pharmaceutical | 1,659.51B |
| Pulmuone Corporate | 3,380.19B |
| Nongshim Holdings | 858.82B |
| Sajodaerim | 3,499.81B |
| Samyang | 2,562.50B |